Greatmark Investment Partners, Inc. Gilead Sciences, Inc. Transaction History

Greatmark Investment Partners, Inc.

$737 Million
Q3 2024

A detailed history of Greatmark Investment Partners, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Greatmark Investment Partners, Inc. holds 32,412 shares of GILD stock, worth $2.92 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

32,412

Previous 30,677 5.66%

Holding current value

$2.92 Million

Previous $2.1 Million 29.09%

% of portfolio

0.37%

Previous 0.31%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$66.59 - $83.99 $115,533 - $145,722	1,735 Added 5.66%	32,412 $2.72 Million
Q2 2024 Aug 08, 2024	SELL	$63.15 - $72.88 $4,104 - $4,737	-65 Reduced 0.21%	30,677 $2.1 Million
Q1 2024 May 09, 2024	BUY	$71.58 - $87.29 $69,432 - $84,671	970 Added 3.26%	30,742 $2.25 Million
Q4 2023 Feb 05, 2024	BUY	$73.27 - $83.09 $2,271 - $2,575	31 Added 0.1%	29,772 $2.41 Million
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $171,910 - $187,557	2,325 Added 8.48%	29,741 $2.23 Million
Q2 2023 Aug 02, 2023	SELL	$76.01 - $86.7 $74,413 - $84,879	-979 Reduced 3.45%	27,416 $2.11 Million
Q1 2023 Apr 28, 2023	SELL	$77.31 - $88.08 $33,707 - $38,402	-436 Reduced 1.51%	28,395 $2.36 Million
Q4 2022 Jan 30, 2023	BUY	$62.32 - $89.47 $311 - $447	5 Added 0.02%	28,831 $2.48 Million
Q3 2022 Nov 08, 2022	SELL	$59.54 - $68.01 $14,289 - $16,322	-240 Reduced 0.83%	28,826 $1.78 Million
Q2 2022 Jul 28, 2022	BUY	$57.72 - $65.01 $194,805 - $219,408	3,375 Added 13.14%	29,066 $1.8 Million
Q1 2022 Apr 27, 2022	SELL	$57.92 - $72.58 $129,161 - $161,853	-2,230 Reduced 7.99%	25,691 $1.53 Million
Q4 2021 Feb 03, 2022	SELL	$64.88 - $73.64 $251,409 - $285,355	-3,875 Reduced 12.19%	27,921 $2.03 Million
Q3 2021 Nov 02, 2021	BUY	$67.69 - $73.03 $142,487 - $153,728	2,105 Added 7.09%	31,796 $2.22 Million
Q2 2021 Aug 23, 2021	SELL	$63.47 - $69.35 $2.14 Million - $2.34 Million	-33,713 Reduced 53.17%	29,691 $2.05 Million
Q1 2021 May 04, 2021	SELL	$60.0 - $68.46 $440,640 - $502,770	-7,344 Reduced 10.38%	63,404 $4.1 Million
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $1.35 Million - $1.53 Million	-23,775 Reduced 25.15%	70,748 $4.12 Million
Q3 2020 Oct 28, 2020	SELL	$62.1 - $78.08 $79,488 - $99,942	-1,280 Reduced 1.34%	94,523 $5.97 Million
Q2 2020 Aug 04, 2020	SELL	$72.34 - $84.0 $310,193 - $360,192	-4,288 Reduced 4.28%	95,803 $7.37 Million
Q1 2020 Apr 29, 2020	SELL	$62.63 - $80.22 $312,836 - $400,698	-4,995 Reduced 4.75%	100,091 $7.48 Million
Q4 2019 Jan 31, 2020	SELL	$61.62 - $67.78 $645,839 - $710,402	-10,481 Reduced 9.07%	105,086 $6.83 Million
Q3 2019 Oct 30, 2019	SELL	$62.51 - $69.0 $71,448 - $78,867	-1,143 Reduced 0.98%	115,567 $7.33 Million
Q2 2019 Aug 05, 2019	BUY	$61.87 - $69.38 $372,704 - $417,945	6,024 Added 5.44%	116,710 $7.89 Million
Q1 2019 May 07, 2019	BUY	$62.53 - $70.05 $964,837 - $1.08 Million	15,430 Added 16.2%	110,686 $7.2 Million
Q4 2018 Feb 01, 2019	BUY	$60.54 - $79.0 $119,263 - $155,630	1,970 Added 2.11%	95,256 $5.96 Million
Q3 2018 Oct 31, 2018	BUY	$71.28 - $78.92 $375,146 - $415,355	5,263 Added 5.98%	93,286 $7.2 Million
Q2 2018 Aug 03, 2018	BUY	$64.88 - $75.68 $234,087 - $273,053	3,608 Added 4.27%	88,023 $6.24 Million
Q1 2018 May 04, 2018	BUY	$72.84 - $88.8 $517,965 - $631,456	7,111 Added 9.2%	84,415 $6.36 Million
Q4 2017 Feb 01, 2018	BUY	$71.15 - $83.52 $142,940 - $167,791	2,009 Added 2.67%	77,304 $5.54 Million
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $5.43 Million - $6.44 Million	75,295	75,295 $6.1 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greatmark Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greatmark Investment Partners, Inc. with notifications on news.

Account

Greatmark Investment Partners, Inc. Gilead Sciences, Inc. Transaction History